While we have improved in leaps and bounds when it comes to treating cancer, these advances don’t matter if patients aren’t able to access treatments at all. For cancer patients in rural Sarawak, access to healthcare facilities is often hindered by geography, financial cost, as well as the lack of healthcare facilities and specialists in the state. Consultant urologist Dr George Lee is joined by Chris Cheng, president of the Society of Cancer Advocacy & Awareness Kuching (SCAN), a patient advocacy group, to find out why Sarawak needs its own cancer centre and what that might look like in the largest state in our country. 


Image Credit: Wikimedia/Creative Commons

While we have improved in leaps and bounds when it comes to treating cancer, these advances don’t matter if patients aren’t able to access treatments at all. For cancer patients in rural Sarawak, access to healthcare facilities is often hindered by geography, financial cost, as well as the lack of healthcare facilities and specialists in the state. Consultant urologist Dr George Lee is joined by Chris Cheng, president of the Society of Cancer Advocacy &amp; Awareness Kuching (SCAN), a patient advocacy group, to find out why Sarawak needs its own cancer centre and what that might look like in the largest state in our country.&nbsp; Image Credit: Wikimedia/<a target="_blank" rel="noopener noreferrer nofollow" href="http://creativecommons.org/licenses/by-sa/4.0/">Creative Commons</a>

Wander and be enlightened by the endlessly fascinating inner universe that is the human body. We speak with experts, Nobel laureates, cancer survivors and healthcare workers who share their unique perspectives on wellness and living and the latest medical research.

Health & Living

Doctor in the House: Sarawak Needs Its Own Cancer Centre

Malaysia’s healthcare system, skilled workforce, and diverse population presents an attractive proposition for global pharmaceutical companies looking to conduct multicentre clinical trials. In 2023, Malaysia ranked second in the Southeast Asian region in terms of the number of global industry-sponsored studies. How do we maintain our potential as a regional hub for clinical trials, especially moving up the value chain to focus more on Phase 1, or first-in-human, clinical trials? Dr Akhmal Yusof, Chief Executive Officer of Clinical Research Malaysia, and Dr Mohamed Elwakil, Country President of Novartis Malaysia, join Dr George Lee to discuss.


Image credit: Clinical Research Malaysia Facebook

Malaysia’s healthcare system, skilled workforce, and diverse population presents an attractive proposition for global pharmaceutical companies looking to conduct multicentre clinical trials. In 2023, Malaysia ranked second in the Southeast Asian region in terms of the number of global industry-sponsored studies. How do we maintain our potential as a regional hub for clinical trials, especially moving up the value chain to focus more on Phase 1, or first-in-human, clinical trials? Dr Akhmal Yusof, Chief Executive Officer of Clinical Research Malaysia, and Dr Mohamed Elwakil, Country President of Novartis Malaysia, join Dr George Lee to discuss. Image credit: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/clinicalresearchmalaysia/">Clinical Research Malaysia Facebook</a>

Doctor in the House: Can Malaysia Be A Regional Hub for Clinical Trials?

Consultant developmental paediatrician Dr Rajini Sarvananthan joins us on her monthly show to commemorate World Autism Awareness Day, in a conversation with Nik Didi, a parent to two autistic girls. We explore the joys and challenges of parenting neurodivergent children, and find out more about the support that parents need.


Image credit: Nik Didi

Consultant developmental paediatrician Dr Rajini Sarvananthan joins us on her monthly show to commemorate World Autism Awareness Day, in a conversation with Nik Didi, a parent to two autistic girls. We explore the joys and challenges of parenting neurodivergent children, and find out more about the support that parents need. Image credit: Nik Didi

Life With Autistic Daughters

For a long time, dengue fever is often diagnosed among populations living in tropical and subtropical climates because that is the environment where the Aedes mosquitoes - the vector of the virus - thrives in. But as climate change causes temperatures the rise, the mosquitoes are now able to live and thrive in more temperate countries, exposing more people to the virus. Will this be the wake-up call that the world needs to better address dengue fever - which has yet to have an effective treatment? Joining me to share her insights and what it would mean for dengue to be seen as a global health threat, is Dr Dinu Guruge, an epidemiologist and consultant for the Global Dengue Program under the Drugs for Neglected Diseases Initiative.



Image credit: Shutterstock

For a long time, dengue fever is often diagnosed among populations living in tropical and subtropical climates because that is the environment where the Aedes mosquitoes - the vector of the virus - thrives in. But as climate change causes temperatures the rise, the mosquitoes are now able to live and thrive in more temperate countries, exposing more people to the virus. Will this be the wake-up call that the world needs to better address dengue fever - which has yet to have an effective treatment? Joining me to share her insights and what it would mean for dengue to be seen as a global health threat, is Dr Dinu Guruge, an epidemiologist and consultant for the Global Dengue Program under the Drugs for Neglected Diseases Initiative.Image credit: Shutterstock

Doctor in the House: Sarawak Needs Its Own Cancer Centre

In 1 playlist(s)

Health & Living

Social links

Follow podcast

Recent clips